| Amyloidosis |
1 |
1 |
| Genomic Medicine |
0 |
1 |
| CRISPR |
0 |
1 |
| Gene Editing |
0 |
1 |
| Cardiomyopathy |
0 |
0.44 |
| Heart |
0 |
0.28 |
| Heart Failure (HF) |
0 |
0.24 |
| Aminotransferase |
0 |
0.15 |
| Grant |
0 |
0.14 |
| Liver |
0 |
0.14 |
| Beta-Thalassemia |
0 |
0.1 |
| Bone Marrow |
0 |
0.1 |
| Lysosomal Storage Disease |
0 |
0.1 |
| Sickle Cell Anemia |
0 |
0.08 |
| Board Certification |
0 |
0.07 |
| Bone |
0 |
0.07 |
| Chronic Disease |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| I-Cell Disease |
0 |
0.07 |
| Intravenous |
0 |
0.07 |
| New York |
0 |
0.07 |
| Pennsylvania |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Thalassemia |
0 |
0.07 |
| Tissue |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Stem Cell Research and Therapy |
0 |
0.06 |